Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Italian real life experience with brentuximab vedotin: results of a large observational study on 234 relapsed/refractory Hodgkin's lymphoma.

Pellegrini C, Broccoli A, Pulsoni A, Rigacci L, Patti C, Gini G, Mannina D, Tani M, Rusconi C, Romano A, Vanazzi A, Botto B, Santoro A, Hoaus S, Rigolin GM, Musto P, Mazza P, Molica S, Corradini P, Fama A, Gaudio F, Merli M, Ronconi F, Gritti G, Vallisa D, Tosi P, Liberati AM, Pinto A, Pavone V, Gherlinzoni F, Bianchi MP, Volpetti S, Trentin L, Goldaniga MC, Bonfichi M, De Renzo A, Schiavotto C, Spina M, Carella AM, Stefoni V, Argnani L, Zinzani PL.

Oncotarget. 2017 May 23;8(53):91703-91710. doi: 10.18632/oncotarget.18114. eCollection 2017 Oct 31.

2.

Charge injection into nanostructured TiO2 electrodes from the photogenerated reduced form of a new Ru(ii) polypyridine compound: the "anti-biomimetic" mechanism at work.

Ronconi F, Santoni MP, Nastasi F, Bruno G, Argazzi R, Berardi S, Caramori S, Bignozzi CA, Campagna S.

Dalton Trans. 2016 Sep 28;45(36):14109-23. doi: 10.1039/c6dt01970f. Epub 2016 Aug 18.

PMID:
27537828
3.

Modification of nanocrystalline WO3 with a dicationic perylene bisimide: applications to molecular level solar water splitting.

Ronconi F, Syrgiannis Z, Bonasera A, Prato M, Argazzi R, Caramori S, Cristino V, Bignozzi CA.

J Am Chem Soc. 2015 Apr 15;137(14):4630-3. doi: 10.1021/jacs.5b01519. Epub 2015 Apr 2.

PMID:
25837588
4.

High CD20+ background cells predict a favorable outcome in classical Hodgkin lymphoma and antagonize CD68+ macrophages.

Panico L, Tenneriello V, Ronconi F, Lepore M, Cantore N, Dell'Angelo AC, Ferbo L, Ferrara F.

Leuk Lymphoma. 2015 Jun;56(6):1636-42. doi: 10.3109/10428194.2014.951849. Epub 2014 Nov 3.

PMID:
25098425
5.

Pulsed-laser deposition of nanostructured iron oxide catalysts for efficient water oxidation.

Orlandi M, Caramori S, Ronconi F, Bignozzi CA, El Koura Z, Bazzanella N, Meda L, Miotello A.

ACS Appl Mater Interfaces. 2014 May 14;6(9):6186-90. doi: 10.1021/am501021e. Epub 2014 Apr 22.

PMID:
24742340
6.

Eudragit(®) microparticles for the release of budesonide: a comparative study.

Cortesi R, Ravani L, Menegatti E, Esposito E, Ronconi F.

Indian J Pharm Sci. 2012 Sep;74(5):415-21. doi: 10.4103/0250-474X.108416.

7.

Prognostic role of tumor-associated macrophages and angiogenesis in classical Hodgkin lymphoma.

Panico L, Ronconi F, Lepore M, Tenneriello V, Cantore N, Dell'Angelo AC, Ferbo U, Ferrara F.

Leuk Lymphoma. 2013 Nov;54(11):2418-25. doi: 10.3109/10428194.2013.778405. Epub 2013 Apr 11.

PMID:
23432688
8.

Peripheral T-cell Lymphoma with Cyclin D1 overexpression: a case report.

Aquino G, Franco R, Ronconi F, Anniciello A, Russo L, De Chiara A, Panico L.

Diagn Pathol. 2012 Jul 6;7:79. doi: 10.1186/1746-1596-7-79.

9.

Changing the magnetism of amorphous FeSiB by mechanical milling.

Del Bianco L, Spizzo F, Tamisari M, Bonetti E, Ronconi F, Fiorani D.

J Phys Condens Matter. 2010 Jul 28;22(29):296010. doi: 10.1088/0953-8984/22/29/296010. Epub 2010 Jul 7.

PMID:
21399327
10.

Randomized trial of fludarabine versus fludarabine and idarubicin as frontline treatment in patients with indolent or mantle-cell lymphoma.

Zinzani PL, Magagnoli M, Moretti L, De Renzo A, Battista R, Zaccaria A, Guardigni L, Mazza P, Marra R, Ronconi F, Lauta VM, Bendandi M, Gherlinzoni F, Gentilini P, Ciccone F, Cellini C, Stefoni V, Ricciuti F, Gobbi M, Tura S.

J Clin Oncol. 2000 Feb;18(4):773-9.

PMID:
10673518
11.

Fludarabine-based chemotherapy in untreated mantle cell lymphomas: an encouraging experience in 29 patients.

Zinzani PL, Magagnoli M, Moretti L, Battista R, Ronconi F, De Renzo A, Zaccaria A, Gentilini P, Guardigni L, Gherlinzoni F, Cellini C, Fattori PP, Bendandi M, Bocchia M, Aitini E, Tura S.

Haematologica. 1999 Nov;84(11):1002-6.

12.

How do patients with aggressive non-Hodgkin's lymphoma treated with third-generation regimens (MACOP-B and F-MACHOP) fare in the long-term?

Zinzani PL, Martelli M, Magagnoli M, Zaja F, Storti S, Pavone E, Lauta VM, De Renzo A, Gobbi M, Bocchia M, Ronconi F, Scaramucci L, Gherlinzoni F, Palombi F, Bendandi M, Stefoni V, Anticoli Borza P, Cellini C, Mandelli F, Tura S.

Haematologica. 1999 Nov;84(11):996-1001.

13.

Anaplastic large cell lymphoma Hodgkin's-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy.

Zinzani PL, Martelli M, Magagnoli M, Zaccaria A, Ronconi F, Cantonetti M, Bocchia M, Marra R, Gobbi M, Falini B, Gherlinzoni F, Moretti L, De Renzo A, Mazza P, Pavone E, Sabattini E, Amendola A, Bendandi M, Pileri SA, Mandelli F, Tura S.

Blood. 1998 Aug 1;92(3):790-4.

14.

A new combination chemotherapy for advanced chronic lymphocytic leukemia (vincristine, cyclophosphamide, melphalan, peptichemio, and prednisone protocol).

Ferrara F, Del Vecchio L, Mele G, Rametta V, Ronconi F, Montuori R.

Cancer. 1989 Aug 15;64(4):789-92.

PMID:
2743271
15.

An analysis of morphological, cytochemical, immunological and clinical features of adult T cell acute lymphoblastic leukemia.

Ferrara F, Del Vecchio L, Fasanaro A, Rametta V, Ronconi F, Montuori R.

Ric Clin Lab. 1988 Jan-Mar;18(1):45-51.

PMID:
3259715
16.

[Chronic myeloid leukemia in childhood. Clinico-hematologic study of 40 cases].

Ferrara F, Martino A, Matera C, Prossomariti L, Rametta V, Ronconi F, Montuori R.

Minerva Pediatr. 1987 Jan 31;39(1-2):15-8. Italian. No abstract available.

PMID:
3474497

Supplemental Content

Loading ...
Support Center